Prenatal Substance Exposure, Impact on the Child to Adulthood

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Neurology & Neurodevelopmental Disorders".

Deadline for manuscript submissions: closed (10 June 2024) | Viewed by 31113

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Newborn Care, The Royal Hospital for Women, Barker Street, Randwick, NSW 2031, Australia
2. School of Women’s and Children’s Health, Faculty of Medicine, University of New South Wales, High Street, Randwick, NSW 2031, Australia
Interests: the use of oxygen in neonatal research; the effects of maternal drugs of dependency on the neonate, including neuroimaging, parenting and long-term follow-up; epidemiology of neonatal intensive care and outcomes; clinical trials; newborn pain; parenting and long-term follow-up

E-Mail Website
Guest Editor
1. Department of Development and Regeneration, KU Leuven, Leuven, Belgium
2. Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
3. Department of Clinical Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands
Interests: perinatal pharmacology; neonatal pharmacology; pediatric pain; neonatal outcome; pharmacokinetics; pharmacodynamics; drug safety
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue on Neonatal Abstinence Syndrome (NAS) explores the consequences of prenatal drug exposure beyond the immediate neonatal period. NAS has the potential to affect a child even after resolution of withdrawal, precipitating a gamut of biological, genetic, and societal changes that may, more often than not, result in detrimental outcomes for not only the child but also his/her family and the whole society. This Special Issue encourages clinicians, families, and policy-makers to consider strategies that will minimize and reduce the impact of NAS on both an individual and a societal level.

Prof. Dr. Ju-Lee Oei
Prof. Dr. Karel Allegaert
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neonatal abstinence syndrome
  • prenatal drug exposure
  • long-term outcomes
  • adult outcomes
  • mental health
  • neurodevelopment
  • academic outcomes
  • child maltreatment
  • policy and guidelines
  • pharmacotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research

3 pages, 647 KiB  
Editorial
Neonatal Abstinence Syndrome: Prevention, Management and Outcomes: From Birth to Adulthood
by Karel Allegaert and Ju-Lee Oei
Children 2022, 9(8), 1151; https://doi.org/10.3390/children9081151 - 30 Jul 2022
Cited by 1 | Viewed by 2582
Abstract
Neonatal abstinence syndrome (NAS), or—when specifically focused on opioids—neonatal opioid withdrawal syndrome (NOWS) is a withdrawal syndrome in neonates after birth causally related to the in utero exposure to drugs of dependence, and the subsequent acute interruption at delivery [...] Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Figure 1

Research

Jump to: Editorial

11 pages, 2158 KiB  
Article
Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity
by Jennifer S. Miller, Henrietta S. Bada, Philip M. Westgate, Thitinart Sithisarn and Markos Leggas
Children 2024, 11(2), 203; https://doi.org/10.3390/children11020203 - 5 Feb 2024
Viewed by 1427
Abstract
Neonatal abstinence syndrome (NAS) presents with a varying severity of withdrawal signs and length of treatment (LOT). We examined the course and relevance of each of the NAS withdrawal signs during treatment in a sample of 182 infants with any prenatal opioid exposure, [...] Read more.
Neonatal abstinence syndrome (NAS) presents with a varying severity of withdrawal signs and length of treatment (LOT). We examined the course and relevance of each of the NAS withdrawal signs during treatment in a sample of 182 infants with any prenatal opioid exposure, gestational age ≥ 35 weeks, without other medical conditions, and meeting the criteria for pharmacological treatment. Infants were monitored using the Finnegan Neonatal Abstinence Scoring Tool. Daily mean Finnegan scores were estimated using linear mixed models with random subject effects to account for repeated withdrawal scores from the same subject. Daily item prevalence was estimated using generalized estimating equations with a within-subject exchangeable correlation structure. The median LOT was 12.86 days. The prevalence of withdrawal signs decreased from day one to day three of treatment. However, certain central nervous system (CNS) and gastrointestinal (GI) signs showed sporadic increases in prevalence notable around two weeks of treatment, accounting for increases in Finnegan scores that guided pharmacotherapy. We question whether the resurgence of signs with a prolonged LOT is mainly a consequence of opioid tolerance or withdrawal. Monitoring CNS and GI signs throughout treatment is crucial. Future studies directed to better understand this clinical phenomenon may lead to the refining of NAS pharmacotherapy and perhaps the discovery of treatment alternatives. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Graphical abstract

11 pages, 563 KiB  
Article
Improving the Assessment of Neonatal Abstinence Syndrome (NAS)
by Claire A. Chin Foo, Lynne M. Dansereau, Katheleen Hawes, Erica L. Oliveira and Barry M. Lester
Children 2021, 8(8), 685; https://doi.org/10.3390/children8080685 - 9 Aug 2021
Cited by 6 | Viewed by 3980
Abstract
Neonatal Abstinence Syndrome (NAS) is a public health problem of epidemic proportions. The Finnegan Neonatal Abstinence Scoring System (FNASS) is the tool most widely used to evaluate NAS. However, it is limited by its lack of interrater reliability and standardized approach. Surveys to [...] Read more.
Neonatal Abstinence Syndrome (NAS) is a public health problem of epidemic proportions. The Finnegan Neonatal Abstinence Scoring System (FNASS) is the tool most widely used to evaluate NAS. However, it is limited by its lack of interrater reliability and standardized approach. Surveys to evaluate the FNASS were distributed to nurses at the Women and Infants Hospital in Providence, RI, USA. Infants (n = 78) treated for NAS and born to methadone-maintained mothers were examined to compare items administered from the FNASS and the NICU Network Neurobehavioral Scale (NNNS). All nurses reported that the FNASS was somewhat to very subjective. More than half reported that it was somewhat to not accurate and a new scoring method is needed to accurately diagnose NAS. Correlations between FNASS items and NNNS items showed 9 of 32 (28.1%) correlations were strong (rs > 0.5), 5 of 32 (15.6%) were moderate (0.3 < rs < 0.5), and 10 of 32 (31.3%) were weak (0.1 < rs < 0.3). Principal component factor analysis (PCA) of the NNNS explained more variance (35.1%) than PCA of NNNS and FNASS items combined (33.1%). The nursing survey supported the need for developing a more objective exam to assess NAS. NNNS exam items may be used to improve the evaluation of NAS. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Figure 1

12 pages, 510 KiB  
Article
Australian Foster Carers’ Views and Concerns Regarding Maternal Drug Use and the Safety of Breastmilk
by Stacy Blythe, Kath Peters, Emma Elcombe, Elaine Burns and Karleen Gribble
Children 2021, 8(4), 284; https://doi.org/10.3390/children8040284 - 7 Apr 2021
Cited by 3 | Viewed by 3262
Abstract
Parental substance misuse and mental health issues are major factors associated with infant placement into out-of-home care. Such placements may result in disruption and/or cessation of breastfeeding. Provision of breastmilk to infants in out-of-home care (OOHC) is desirable in terms of infant health [...] Read more.
Parental substance misuse and mental health issues are major factors associated with infant placement into out-of-home care. Such placements may result in disruption and/or cessation of breastfeeding. Provision of breastmilk to infants in out-of-home care (OOHC) is desirable in terms of infant health and development, and also in supporting maternal caregiving. However, little is known about how breastfeeding is supported for infants in out-of-home care. This study used an online survey to explore the facilitation of breastfeeding in the context of OOHC and foster carers’ management of expressed breastmilk (EBM). Foster carers were generally open to the idea of maternal breastfeeding and infants in their care receiving EBM from their mothers. However, the majority of respondents expressed concern regarding the safety of EBM for infant consumption due to the possibility of harmful substances in the milk. Concerns regarding the safety of handling EBM were also prevalent. These concerns caused foster carers to discard EBM. Findings suggest foster carers’ may lack knowledge related to maternal substance use and breastmilk. Better integration between health care and social service systems, where the voices of mothers, foster carers and child protection workers are heard, is necessary to develop solutions enabling infants living in OOHC access to their mother’s breastmilk. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Figure 1

15 pages, 854 KiB  
Article
Preschool Language Development of Children Born to Women with an Opioid Use Disorder
by Hyun Min Kim, Reisha M. Bone, Brigid McNeill, Samantha J. Lee, Gail Gillon and Lianne J. Woodward
Children 2021, 8(4), 268; https://doi.org/10.3390/children8040268 - 31 Mar 2021
Cited by 14 | Viewed by 5457
Abstract
Increasing evidence suggests that prenatal exposure to opioids may affect brain development, but limited data exist on the effects of opioid-exposure on preschool language development. Our study aimed to characterize the nature and prevalence of language problems in children prenatally exposed to opioids, [...] Read more.
Increasing evidence suggests that prenatal exposure to opioids may affect brain development, but limited data exist on the effects of opioid-exposure on preschool language development. Our study aimed to characterize the nature and prevalence of language problems in children prenatally exposed to opioids, and the factors that support or hinder language acquisition. A sample of 100 children born to pregnant women in methadone maintenance treatment and 110 randomly identified non-exposed children were studied from birth to age 4.5 years. At 4.5 years, 89 opioid-exposed and 103 non-exposed children completed the preschool version of the Clinical Evaluation of Language Fundamentals (CELF-P) as part of a comprehensive neurodevelopmental assessment. Children prenatally exposed to opioids had poorer receptive and expressive language outcomes at age 4.5 years compared to non-opioid exposed children. After adjustment for child sex, maternal education, other pregnancy substance use, maternal pregnancy nutrition and prenatal depression, opioid exposure remained a significant independent predictor of children’s total CELF-P language score. Examination of a range of potential intervening factors showed that a composite measure of the quality of parenting and home environment at age 18 months and early childhood education participation at 4.5 years were important positive mediators. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Figure 1

10 pages, 711 KiB  
Article
Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
by Samira Samiee-Zafarghandy, Tamara van Donge, Karel Allegaert and John van den Anker
Children 2021, 8(3), 174; https://doi.org/10.3390/children8030174 - 25 Feb 2021
Cited by 1 | Viewed by 1907
Abstract
In methadone-exposed preterm neonates, early identification of those at risk of severe neonatal abstinence syndrome (NAS) and use of a methadone dosing regimen that can provide effective and safe drug exposure are two important aspects of optimal care. To this end, we reviewed [...] Read more.
In methadone-exposed preterm neonates, early identification of those at risk of severe neonatal abstinence syndrome (NAS) and use of a methadone dosing regimen that can provide effective and safe drug exposure are two important aspects of optimal care. To this end, we reviewed 17 methadone dosing recommendations in the international guidelines and literature and explored their variability in key dosing strategies. We selected three of the reviewed dosing regimens for their pharmacokinetics (PK) characteristics and their exposure–response relationship in three gestational age groups of preterm neonates (28, 32 and 36 gestational age weeks) at risk for development of severe NAS (defined as an umbilical cord methadone concentration of ≤60 ng/mL, following fetal exposure). We applied early (12 h after birth) vs. typical (36 h after birth) initiation of treatment. We observed that use of universally recommended dosing regimens in preterm neonates can result in under- or over-exposure. Use of a PK-guided dosing regimen resulted in effective target exposures within 24 h after birth with early initiation of treatment (12 h after birth). Future prospective studies should explore the incorporation of umbilical cord methadone concentrations for early identification of preterm neonates at risk of developing severe NAS and investigate the use of a PK-guided methadone dosing regimen, so that treatment failure, prolonged length of stay and opioid over-exposure can be avoided. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Figure 1

13 pages, 228 KiB  
Article
The Challenges to Promoting Attachment for Hospitalised Infants with NAS
by Jaylene Shannon, Kath Peters and Stacy Blythe
Children 2021, 8(2), 167; https://doi.org/10.3390/children8020167 - 22 Feb 2021
Cited by 11 | Viewed by 5125
Abstract
The postnatal period is crucial for infants in establishing a connection with and security in primary caregivers and can have enduring effects on attachment patterns. However, due to the need for symptom management, many infants diagnosed with neonatal abstinence syndrome (NAS) may be [...] Read more.
The postnatal period is crucial for infants in establishing a connection with and security in primary caregivers and can have enduring effects on attachment patterns. However, due to the need for symptom management, many infants diagnosed with neonatal abstinence syndrome (NAS) may be separated from primary caregivers and cared for in a neonatal intensive care unit (NICU) or special care nursery (SCN) soon after birth. Research has shown that substance-exposed infants are more likely to experience insecure attachment patterns with their primary caregivers and that mothers with a history of substance abuse are less sensitive to their infants’ cues. Therefore, the aim of this research was to explore nurses’ and midwives’ experiences in promoting the attachment relationship for infants admitted to an NICU/SCN with NAS. A qualitative research design was used to gather data on the experiences of nine nurses/midwives from various NICU and SCN settings in Australia. Individual, semi-structured interviews were conducted, and transcribed interviews were coded using thematic analysis. While nurses/midwives valued the attachment relationship for infants with NAS, facilitation of the attachment relationship was mainly promoted when the mother was present. However, parents were often reported to be absent from the nursery. Difficulties in promoting an attachment relationship were also identified when an infant had child protection involvement. This research identifies areas in need of innovative change regarding the approach taken to promote the attachment relationship for infants with NAS when they are admitted to an NICU/SCN. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Graphical abstract

11 pages, 219 KiB  
Article
The Complexities Associated with Caring for Hospitalised Infants with Neonatal Abstinence Syndrome: The Perspectives of Nurses and Midwives
by Jaylene Shannon, Stacy Blythe and Kath Peters
Children 2021, 8(2), 152; https://doi.org/10.3390/children8020152 - 17 Feb 2021
Cited by 10 | Viewed by 5092
Abstract
The global incidence of Neonatal Abstinence Syndrome (NAS) has increased significantly in the last decade. Symptoms of NAS manifest from the central and autonomic nervous systems as well as the gastrointestinal system and vary in severity and duration. The clinical management of infants [...] Read more.
The global incidence of Neonatal Abstinence Syndrome (NAS) has increased significantly in the last decade. Symptoms of NAS manifest from the central and autonomic nervous systems as well as the gastrointestinal system and vary in severity and duration. The clinical management of infants experiencing NAS is dependent on symptoms and may include both pharmacological and non-pharmacological measures. In cases where symptoms are severe, infants may be admitted to special care nurseries or neonatal intensive care units. Existing research on nurses’ involvement in caring for infants with NAS focuses on pharmacological and non-pharmacological interventions to treat physical symptoms associated with NAS. This research sought to add to the body of knowledge around NAS and conveys nurses’ and midwives’ experiences of delivering care for infants with NAS. Semi-structured interviews were held with nine nurses/midwives. Interviews were audio-recorded, transcribed verbatim and thematically analysed. Five themes emerged from the data. These themes are: Complex care needs; Prioritising physiological care; Experiencing compassion fatigue; Lacking continuity of care; and Stigma. The findings demonstrated the complex nature of care provision for infants with NAS. Competing priorities and the stigmatising nature of NAS threaten optimal care being delivered to these vulnerable infants and their parents. Full article
(This article belongs to the Special Issue Prenatal Substance Exposure, Impact on the Child to Adulthood)
Show Figures

Graphical abstract

Back to TopTop